January 6, 2015 — Valeant Pharmaceuticals, LLC is voluntarily recalling one lot of Virazole, a powdered nasal solution, due to possible microbial contamination.
There are no illnesses or injuries linked to the recalled medication. Only one lot is being recalled: Lot No. 340353F, expiration date October 2018. It was distributed in the United States and Australia.
The product is packaged in 100 mL, 6 g vials in a 4-pack. It is intended to be reconstituted using 300 mL of sterile water into a solution.
Virazole (ribavirin) is a powdered medication that is made into a solution before it is injected or inhaled by a patient. It is approved by the FDA for the treatment of infants or young children who are infected with respiratory syncytial virus (RSV).
Many patients who need Virazole already have a severe lower respiratory tract infection. Inhalation of additional bacteria could significantly worsen their condition.
The FDA warns:
“Inhalation of a non-sterile product with microbial contamination into the airways could increase the risk of respiratory infection. The risk is higher in patients who are immunocompromised (because of underlying disease), and are more susceptible.”
Do I have a Pharmaceutical Injury Lawsuit?
The Schmidt Firm, PLLC is currently accepting pharmaceutical induced injury cases in all 50 states. If you or somebody you know has been injured by a contaminated medication, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.